$CORR base breakout alertNASDAQ:CORT broke out of the base with high volume. A good entry would be when it retraces to support in the next few days.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.18 EUR
134.98 M EUR
652.07 M EUR
93.70 M
About Corcept Therapeutics Incorporated
Sector
Industry
CEO
Joseph K. Belanoff
Website
Headquarters
Redwood City
Founded
1998
FIGI
BBG01TNXLB36
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.
Corcept Therapeutics: A Shining Star in US BiotechCorcept Therapeutics is making waves in the booming U.S. biotech scene, with its stock surging 46.2% over the past six months. The company, known for its Cushing's syndrome drug, Korlym, reported a staggering 39.1% year-over-year sales increase, reaching $310.6 million in H1 2024. With a market cap
Sideways and almost ready.Price consolidated sideways for a few days, and it wants to break higher to retest previous highs.
LONG CORTIf the market pulls back, this will too. But we are at a level of support, so low volatility entry will allow us to manage the risk on this trade better. Breaking that support, we would close the trade.
CORT, MACD Histogram just turned positiveThis is a Bullish indicator signaling CORT's price could rise from here. Traders may explore going long the stock or buying call options. Tickeron's A.I. dvisor identified 48 similar cases where CORT's MACD histogram became positive, and 42 of them led to successful outcomes. Odds of Success: 88%. C
U.S. Patent Trial and Appeals Board Affirms ValidityU.S. Patent Trial and Appeals Board Affirms Validity of All Claims of Corcept’s U.S. Patent No.10,195,214
announced today that the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office has issued a decision upholding the validity of all claims of U.S. Patent No. 10,195,214, “
CORT Potential Long: fundamentals and shortOnly an idea.
Industry ranked 37 in biotech. 3b market cap.
Big buy happened.
Current ratio of debt coverage is 10. :)
Modest growth 6% of ROE Q/Q: :| compared to others
Current volume trend is above normal, but 20day volume is below. so wait to see.
The dip is coming and then a run up.
Double bott
PAY to CORCEPT THERAPEUTICS DailyHey traders, CORCEPT THERAPEUTICS is in a fake bearish move with low sell volume executed and a water carrier with strong shadow of buyers. In the TIMEFRAME M1 we can see a mini marubozu bull with a low purchase volume. Strong potential for breakout the price of going on its last precedent higher af
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Related stocks
Frequently Asked Questions
The current price of 1CORT is 62.40 EUR — it has decreased by −2.64% in the past 24 hours. Watch CORCEPT THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange CORCEPT THERAPEUTICS INC stocks are traded under the ticker 1CORT.
1CORT stock has fallen by −1.41% compared to the previous week, the month change is a −1.01% fall, over the last year CORCEPT THERAPEUTICS INC has showed a −1.52% decrease.
We've gathered analysts' opinions on CORCEPT THERAPEUTICS INC future price: according to them, 1CORT price has a max estimate of 127.51 EUR and a min estimate of 115.20 EUR. Watch 1CORT chart and read a more detailed CORCEPT THERAPEUTICS INC stock forecast: see what analysts think of CORCEPT THERAPEUTICS INC and suggest that you do with its stocks.
1CORT reached its all-time high on May 2, 2025 with the price of 64.46 EUR, and its all-time low was 63.28 EUR and was reached on Apr 30, 2025. View more price dynamics on 1CORT chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1CORT stock is 0.51% volatile and has beta coefficient of 0.20. Track CORCEPT THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is CORCEPT THERAPEUTICS INC there?
Today CORCEPT THERAPEUTICS INC has the market capitalization of 6.60 B, it has increased by 5.13% over the last week.
Yes, you can track CORCEPT THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
CORCEPT THERAPEUTICS INC is going to release the next earnings report on Jul 30, 2025. Keep track of upcoming events with our Earnings Calendar.
1CORT earnings for the last quarter are 0.16 EUR per share, whereas the estimation was 0.13 EUR resulting in a 19.30% surprise. The estimated earnings for the next quarter are 0.16 EUR per share. See more details about CORCEPT THERAPEUTICS INC earnings.
CORCEPT THERAPEUTICS INC revenue for the last quarter amounts to 145.32 M EUR, despite the estimated figure of 164.46 M EUR. In the next quarter, revenue is expected to reach 175.35 M EUR.
1CORT net income for the last quarter is 18.75 M EUR, while the quarter before that showed 29.36 M EUR of net income which accounts for −36.12% change. Track more CORCEPT THERAPEUTICS INC financial stats to get the full picture.
No, 1CORT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 7, 2025, the company has 500 employees. See our rating of the largest employees — is CORCEPT THERAPEUTICS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CORCEPT THERAPEUTICS INC EBITDA is 104.03 M EUR, and current EBITDA margin is 20.49%. See more stats in CORCEPT THERAPEUTICS INC financial statements.
Like other stocks, 1CORT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CORCEPT THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.